LAURA KELSO: Open Payments
NPI 1457123226 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 12 payments from 7 companies in 2025. Trend: 2023 $2,160 · 2024 $95 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $426 |
| Medtronic, Inc. | 2 | $75 |
| Abbott Laboratories | 1 | $50 |
| PFIZER INC. | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 1 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: CARDIOMEMS, VYNDAQEL, AMVUTTRA, LifeVest, FARXIGA.
Industry payments across IL — which companies pay providers there.
